October 8, 2024
An intervention study to improve outcomes for cancer survivors and enhance primary care capacity, funded with a $4.8 million grant from the National Cancer Institute, will be implemented by UTHealth Houston researchers in partnership with eight Texas primary care community health centers that treat under- and uninsured patients.
October 7, 2024
UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease.
The recipient, 79-year-old Terrie Frankel, received the infusion last week.
October 1, 2024
UTHealth Houston School of Public Health will partner with the U.S. Department of Health and Human Services Office of the National Coordinator (ONC) to equip students with the knowledge and skills needed to pursue successful careers in public service, particularly in health and human services.
September 27, 2024
From the outside, there is nothing about successful, busy attorney Brenda Adimora that hints at a disease she has fought all of her life. She maintains an active practice as a labor and employment attorney and was chair of the board of trustees of the Houston Young Lawyers Foundation.
September 25, 2024
Since he could remember, Jesus Mata has always had a cough he could not seem to kick. He had no idea that his simple cough was a sign of a serious and life-altering illness.
September 24, 2024
The undergraduate program at Cizik School of Nursing at UTHealth Houston continues to outrank all others in Texas, according to U.S. News & World Report’s 2025 U.S. News Best Colleges publication, which was released on Tuesday.
September 23, 2024
Findings of a study on a novel and minimally invasive laser therapy for patients with drug-resistant epilepsy caused by periventricular nodular heterotopia (PNVH) have been published by UTHealth Houston researchers in American Neurological Association’s Annals of Neurology.
September 19, 2024
Studies by researchers at UTHealth Houston seeking to understand the underlying pathology of Alzheimer’s disease in order to discover new pathways to treatment have earned multiple awards totaling $3.5 million from the Texas Alzheimer’s Research and Care Consortium (TARCC).
September 18, 2024
UTHealth Houston has made an unprecedented commitment to nursing science by establishing the interdisciplinary Cizik Nursing Research Institute. Building on the momentum of Cizik School of Nursing’s growing portfolio of studies funded by the National Institutes of Health, the institute will provide key resources that nurse scientists need to advance meaningful programs of research.
September 16, 2024
Giuseppe N. Colasurdo, MD, announced today that he will be stepping down from his position as president and Alkek-Williams Distinguished Chair at UTHealth Houston. Colasurdo has served in the role for 12 years—the longest tenure of any UTHealth Houston president—and has overseen a period of tremendous growth for the university.